PatternsRadar
Sign in

VIYASHViyash Scientific Limited

NSE
Full chart
233.23INR+4.16 (+1.82%)Close · 6 Oct 2026
11 Aug 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹10,300 CrMarket cap
48.2P/E (TTM)
53.8%Delivery

Filings & corporate actions

45 results filed
CSV
Next results · Q2 FY27
Expected 2 Nov 2026 – 14 Nov 2026
Estimate: filed 33–45 days after quarter end, last 5 times
Dividend
₹0.50 per share · last 8 Sept 2021
2026
  • 11 AugresultsResults · Q1 FY27 · consolidated and standalone+0.5%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026-1.5%NSE
  • 19 MayresultsResults · Q4 FY26 · consolidated and standalone+10.0%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026+0.4%NSE
  • 5 FebresultsResults · Q3 FY26 · consolidated and standalone-3.5%NSE
  • 21 JanshareholdingShareholding · 31 Dec 2025-2.7%NSE

Reaction to results · all yearsrose on day 0 in 24 of 45 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2711 Aug 2026+0.5%+3.8%+0.2%1.2×
Q4 FY2619 May 2026+10.0%+9.4%+11.0%23.2×
Q3 FY265 Feb 2026-3.5%+3.5%-8.7%1.0×
Q2 FY2614 Nov 2025+0.9%-3.1%-8.0%2.0×
Q1 FY268 Aug 2025+5.2%+4.9%+9.0%1.6×
Q4 FY2520 May 2025+5.5%+9.8%+14.5%2.3×
Q3 FY2511 Feb 2025-0.1%-1.2%-10.3%2.3×
Q2 FY2514 Nov 2024-1.7%+3.4%-5.3%1.2×
Q1 FY2514 Aug 2024+3.3%+20.3%+28.5%5.1×
Q4 FY2416 May 2024-1.6%-7.5%+3.7%1.4×
Q3 FY2414 Feb 2024+5.5%+13.7%-11.3%1.2×
Q2 FY247 Nov 2023-2.3%-4.3%+15.9%0.1×
Q1 FY2411 Aug 2023-9.3%-12.3%-9.2%2.8×
Q4 FY2324 May 2023+0.1%-1.1%+21.4%0.4×
Q3 FY2315 Feb 2023-0.1%-6.0%+2.2%0.7×
Q2 FY238 Nov 2022-6.9%-10.1%-7.7%4.4×
Q1 FY239 Aug 2022-13.3%-10.1%-7.1%2.8×
Q4 FY2226 May 2022-0.1%+1.7%-10.8%1.8×
Q3 FY2212 Feb 2022+6.5%-2.4%-13.4%4.0×
Q2 FY222 Nov 2021-0.1%+4.8%-8.1%1.0×
Q1 FY2211 Aug 2021+11.0%+2.5%-2.9%3.2×
Q4 FY211 Jul 2021+1.2%-3.3%+1.9%1.2×
Q3 FY214 Feb 2021+0.9%+7.8%-0.2%0.4×
Q2 FY217 Nov 2020+0.9%0.0%+12.0%1.3×
Q1 FY2131 Jul 2020+5.4%+21.6%+15.5%2.8×
Q4 FY2013 May 20200.0%+3.0%+5.0%3.9×
Q3 FY2028 Jan 2020+1.5%+9.9%+9.4%1.1×
Q2 FY2014 Nov 2019-0.1%-3.8%-3.4%1.1×
Q1 FY2031 Jul 2019-1.4%-5.2%+8.4%0.4×
Q4 FY1914 May 2019-0.2%+0.1%-3.1%1.6×
Q3 FY196 Feb 2019+6.3%+1.7%+5.4%0.4×
Q2 FY1923 Nov 2018+1.5%+2.6%-1.0%1.5×
Q1 FY1924 Aug 2018+0.6%+8.3%-21.5%1.6×
Q4 FY1825 Jun 2018-3.8%-9.0%-9.1%0.4×
Q3 FY1819 Feb 2018-1.7%+11.5%+10.1%3.5×
Q2 FY1821 Nov 2017-2.3%+3.7%+0.4%0.5×
Q1 FY1821 Aug 2017+0.9%-4.8%+4.2%0.5×
Q4 FY1714 Jun 2017+0.7%+2.2%+4.4%0.1×
Q3 FY1616 Feb 2017+3.1%+6.1%-1.1%0.4×
Q3 FY1716 Feb 2017+3.1%+6.1%-1.1%0.4×
Q2 FY1619 Nov 2016-9.4%-1.0%-6.5%0.9×
Q2 FY1719 Nov 2016-9.4%-1.0%-6.5%0.9×
Q1 FY1627 Sept 2016+3.0%-4.5%-8.6%0.3×
Q1 FY1727 Sept 2016+3.0%-4.5%-8.6%0.3×
Q4 FY1616 May 2016-0.2%-8.4%-3.9%0.1×
Average+0.3%+1.3%+0.1%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+114.4%
Profit YoY+351.3%
Interest cost YoY-2.1%
Revenue QoQ+2.9%
Profit QoQ+19.4%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+48.6%+30.6%+21.7%+17.8%+17.3%+16.5%
Profit+289.0%—+66.2%+19.6%+15.3%+17.9%

Key data

CSV
Open229.00
Day range228.57 – 234.50
52-week range178.13 – 298.00
From 52w high-21.7%
RSI (14)35.5
ATR (14)8.22
Volume14.81L
Avg volume (20D)24.86L
Rel volume0.60×
Volatility (1Y)43.0%
Turnover₹34.5Cr
SMA 50 / 200257.24 / 232.32

Delivery percentage

Latest · 6 Oct 202653.8%
20-day avg54.7%
1-year avg50.0%
Percentile (own history)77th
Range5.3–100.0%
Sessions1,731

Over the last 20 sessions VIYASH settled 54.7% of its traded quantity, which is above average for an NSE equity. Its one-year average is 50.0%, so recent sessions are running 4.7 points higher than usual. The latest session ranks higher than 77% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryPharmaceuticals
PeersDIVISLABLAURUSLABSSUNPHARMAWOCKPHARMADRREDDYMOREPENLAB

Performance returns

CSV
1D1W1M3M6M1Y
Price+1.82%-3.22%-10.45%-16.38%+21.63%+23.06%

Valuation

CSV
Market cap₹10,300 Cr
P/E (TTM)48.2
EPS (TTM)4.84
Shares outstanding43.69Cr
Listed10 Mar 2016

Ownership

CSV
Promoter61.31%
Promoter Δ QoQ0.00 pp
Public38.60%
FII4.50%
DII3.75%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)424.0858.4920.0946.4
YoY chg+15.0%+119.6%+129.0%+114.4%
Net profit (₹ Cr)19.648.566.479.3
YoY chg+209.1%+648.8%+539.5%+351.3%
Net margin4.6%5.7%7.2%8.4%
EPS0.580.871.171.47

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 61.31% · public 38.60%
30 Sept 2021: promoter 53.52%31 Dec 2021: promoter 53.02%31 Mar 2022: promoter 53.02%30 Jun 2022: promoter 52.79%30 Sept 2022: promoter 52.79%31 Dec 2022: promoter 52.79%31 Mar 2023: promoter 52.79%30 Jun 2023: promoter 52.79%30 Sept 2023: promoter 52.79%31 Dec 2023: promoter 52.79%31 Mar 2024: promoter 52.79%30 Jun 2024: promoter 52.78%30 Sept 2024: promoter 52.76%31 Dec 2024: promoter 52.61%31 Mar 2025: promoter 52.61%30 Jun 2025: promoter 52.61%30 Sept 2025: promoter 52.33%16 Dec 2025: promoter 61.43%31 Dec 2025: promoter 61.41%31 Mar 2026: promoter 61.31%30 Jun 2026: promoter 61.31%
2021-092026-06
  • Promoter
  • Public and others
Promoter
61.31%
Public
38.60%
Promoter change
0.00 pp
Filed
20 Jul 2026
FII
4.50%
DII
3.75%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations346.0329.4361.2390.2368.7390.8401.7441.4424.0858.4920.0946.4
Other income1.64.54.02.74.55.81.73.92.214.015.98.3
Total income347.6333.9365.2392.9373.2396.7403.4445.3426.1872.4935.9954.7
Total expenses358.8335.1357.9380.9360.9388.2386.7418.5397.3758.1810.6842.3
└ Finance costs12.612.612.416.414.315.015.114.213.516.814.512.5
└ Depreciation15.415.516.516.317.117.016.115.115.558.560.461.8
Profit before tax(3.1)1.52.612.07.98.116.325.527.273.1125.2112.4
Tax expense3.8(9.2)1.42.91.61.65.98.07.624.658.933.1
Net profit(6.9)10.71.39.16.36.510.417.619.648.566.479.3
EPS-0.340.33-0.040.260.100.140.370.570.590.891.201.51
Net margin-1.99%3.24%0.35%2.32%1.72%1.66%2.58%3.98%4.62%5.65%7.22%8.38%
PBT margin-0.89%0.45%0.73%3.08%2.14%2.07%4.06%5.78%6.41%8.51%13.61%11.88%
Tax rate—-616.03%51.67%24.50%19.75%20.00%36.36%31.15%27.84%33.60%47.00%29.46%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 11 Aug 2026.

VIYASH at a glance

  • VIYASH closed at ₹233.23 on 6 Oct 2026, +1.82% on the day, +23.1% over one year, 21.7% below its 52-week high of ₹298.
  • Delivery was 53.8% of traded quantity on 6 Oct 2026, the 77th percentile of its own 1,731 sessions with a reading (20-session average 54.7%, 1-year average 50.0%).
  • Market capitalisation is ₹10,300 crore at a trailing P/E of 48.2 (trailing EPS ₹4.84).
  • Q1 FY27 results (consolidated, filed 11 Aug 2026): revenue ₹946 crore (+114.4% year on year), net profit ₹79 crore (+351.3%); the price moved +0.5% on the first session after.
  • Promoters held 61.31% at 30 Jun 2026, unchanged on the previous filing.
  • Q2 FY27 results are expected between 2 Nov 2026 and 14 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE807F01027
SeriesEQ
Listed10 Mar 2016
History from10 Mar 2016
Sessions2,615
Turnover rank#419

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE